|
2024-05-17 |
2024-05-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
1,000
-0.8%
62.09
100,000
USD
|
1,000
-0.8%
|
62.09
|
100,000
USD
|
|
|
2024-05-17 |
2024-05-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
1,000
-2.1%
63.84
100,000
USD
|
1,000
-2.1%
|
63.84
|
100,000
USD
|
|
|
2024-05-17 |
2024-05-16 |
S
Sale
|
TANNENBAUM RENEE P
Non-Executive Director
|
1,000
-9.9%
63.87
100,000
USD
|
1,000
-9.9%
|
63.87
|
100,000
USD
|
|
|
2024-05-17 |
2024-05-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
1,000
-1.9%
65.86
100,000
USD
|
1,000
-1.9%
|
65.86
|
100,000
USD
|
|
|
2024-05-13 |
2024-05-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
1,000
-0.4%
67.69
100,000
USD
|
1,000
-0.4%
|
67.69
|
100,000
USD
|
|
|
2024-05-03 |
2024-05-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-7.9%
66.62
1,332,400
USD
|
20,000
-7.9%
|
66.62
|
1,332,400
USD
|
|
|
2024-04-22 |
2024-04-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
16,809
-2.1%
65.17
1,095,443
USD
|
16,809
-2.1%
|
65.17
|
1,095,443
USD
|
|
|
2024-04-22 |
2024-04-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,423
-1.3%
64.98
677,287
USD
|
10,423
-1.3%
|
64.98
|
677,287
USD
|
|
|
2024-04-17 |
2024-04-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
9,520
-1.2%
65.40
622,608
USD
|
9,520
-1.2%
|
65.40
|
622,608
USD
|
|
|
2024-04-17 |
2024-04-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,834
-0.7%
66.20
386,211
USD
|
5,834
-0.7%
|
66.20
|
386,211
USD
|
|
|
2024-04-17 |
2024-04-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
7,414
-0.9%
66.33
491,771
USD
|
7,414
-0.9%
|
66.33
|
491,771
USD
|
|
|
2024-04-15 |
2024-04-12 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
67.79
16,948
USD
|
250
-0.4%
|
67.79
|
16,948
USD
|
|
|
2024-04-02 |
2024-04-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-7.3%
67.25
1,345,000
USD
|
20,000
-7.3%
|
67.25
|
1,345,000
USD
|
|
|
2024-03-13 |
2024-03-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
66.54
16,635
USD
|
250
-0.4%
|
66.54
|
16,635
USD
|
|
|
2024-03-13 |
2024-03-11 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-6.8%
65.81
1,316,200
USD
|
20,000
-6.8%
|
65.81
|
1,316,200
USD
|
|
|
2024-03-11 |
2024-03-11 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
7,787
-4.2%
65.55
510,438
USD
|
7,787
-4.2%
|
65.55
|
510,438
USD
|
|
|
2024-03-11 |
2024-03-08 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-1.2%
67.17
671,700
USD
|
10,000
-1.2%
|
67.17
|
671,700
USD
|
|
|
2024-03-08 |
2024-03-08 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
16,292
-3.8%
67.13
1,093,682
USD
|
16,292
-3.8%
|
67.13
|
1,093,682
USD
|
|
|
2024-03-07 |
2024-03-07 |
S
Sale
|
Marken James G.
SVP OPS & PROD DEV
Officer
|
24,338
-16.4%
66.37
1,615,313
USD
|
24,338
-16.4%
|
66.37
|
1,615,313
USD
|
|
|
2024-03-07 |
2024-03-07 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
15,085
-1.8%
66.35
1,000,890
USD
|
15,085
-1.8%
|
66.35
|
1,000,890
USD
|
|
|
2024-03-08 |
2024-03-06 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
28,965
-6.1%
65.52
1,897,787
USD
|
28,965
-6.1%
|
65.52
|
1,897,787
USD
|
|
|
2024-03-07 |
2024-03-06 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
14,822
-1.7%
65.47
970,396
USD
|
14,822
-1.7%
|
65.47
|
970,396
USD
|
|
|
2024-03-07 |
2024-03-05 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,093
-1.1%
65.35
659,578
USD
|
10,093
-1.1%
|
65.35
|
659,578
USD
|
|
|
2024-03-06 |
2024-03-05 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
5,000
-5.4%
66.00
330,000
USD
|
5,000
-5.4%
|
66.00
|
330,000
USD
|
|
|
2024-03-06 |
2024-03-04 |
S
Sale
|
Pera Antonio R
Non-Executive Director
|
7,000
-20.8%
65.20
456,400
USD
|
7,000
-20.8%
|
65.20
|
456,400
USD
|
|
|
2024-02-13 |
2024-02-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
56.04
14,010
USD
|
250
-0.7%
|
56.04
|
14,010
USD
|
|
|
2024-01-23 |
2024-01-23 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
15,000
-1.7%
56.44
846,600
USD
|
15,000
-1.7%
|
56.44
|
846,600
USD
|
|
|
2024-01-23 |
2024-01-22 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,692
-0.6%
55.95
318,467
USD
|
5,692
-0.6%
|
55.95
|
318,467
USD
|
|
|
2024-01-23 |
2024-01-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
4,524
-0.5%
55.57
251,399
USD
|
4,524
-0.5%
|
55.57
|
251,399
USD
|
|
|
2024-01-18 |
2024-01-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
9,784
-1.1%
55.30
541,055
USD
|
9,784
-1.1%
|
55.30
|
541,055
USD
|
|
|
2024-01-18 |
2024-01-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-1.1%
55.11
551,100
USD
|
10,000
-1.1%
|
55.11
|
551,100
USD
|
|
|
2024-01-18 |
2024-01-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,000
-0.5%
55.63
278,150
USD
|
5,000
-0.5%
|
55.63
|
278,150
USD
|
|
|
2024-01-16 |
2024-01-12 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
56.43
14,108
USD
|
250
-0.7%
|
56.43
|
14,108
USD
|
|
|
2023-12-19 |
2023-12-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
25,000
-2.6%
52.65
1,316,250
USD
|
25,000
-2.6%
|
52.65
|
1,316,250
USD
|
|
|
2023-12-19 |
2023-12-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
13,026
-1.3%
52.44
683,083
USD
|
13,026
-1.3%
|
52.44
|
683,083
USD
|
|
|
2023-12-19 |
2023-12-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,974
-1.2%
52.44
627,917
USD
|
11,974
-1.2%
|
52.44
|
627,917
USD
|
|
|
2023-12-11 |
2023-12-11 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
49.21
12,303
USD
|
250
-0.7%
|
49.21
|
12,303
USD
|
|
|
2023-11-20 |
2023-11-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
13,000
-1.3%
51.00
663,000
USD
|
13,000
-1.3%
|
51.00
|
663,000
USD
|
|
|
2023-11-16 |
2023-11-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
6,448
-0.6%
51.66
333,104
USD
|
6,448
-0.6%
|
51.66
|
333,104
USD
|
|
|
2023-11-16 |
2023-11-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
7,647
-0.8%
53.64
410,185
USD
|
7,647
-0.8%
|
53.64
|
410,185
USD
|
|
|
2023-11-16 |
2023-11-15 |
S
Sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
2,622
-7.4%
53.81
141,090
USD
|
2,622
-7.4%
|
53.81
|
141,090
USD
|
|
|
2023-11-16 |
2023-11-14 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
22,095
-2.1%
53.17
1,174,791
USD
|
22,095
-2.1%
|
53.17
|
1,174,791
USD
|
|
|
2023-11-14 |
2023-11-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.7%
52.03
13,008
USD
|
250
-0.7%
|
52.03
|
13,008
USD
|
|
|
2023-11-13 |
2023-11-10 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
3,000
-4.5%
52.47
157,410
USD
|
3,000
-4.5%
|
52.47
|
157,410
USD
|
|
|
2023-10-19 |
2023-10-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-1.0%
57.06
570,600
USD
|
10,000
-1.0%
|
57.06
|
570,600
USD
|
|
|
2023-10-19 |
2023-10-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
6,242
-0.6%
57.78
360,663
USD
|
6,242
-0.6%
|
57.78
|
360,663
USD
|
|
|
2023-10-19 |
2023-10-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
8,758
-0.8%
58.53
512,606
USD
|
8,758
-0.8%
|
58.53
|
512,606
USD
|
|
|
2023-10-17 |
2023-10-16 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
13,063
-1.2%
58.31
761,704
USD
|
13,063
-1.2%
|
58.31
|
761,704
USD
|
|
|
2023-10-17 |
2023-10-13 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,937
-1.1%
57.58
687,332
USD
|
11,937
-1.1%
|
57.58
|
687,332
USD
|
|
|
2023-10-03 |
2023-10-02 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-6.4%
56.48
1,129,600
USD
|
20,000
-6.4%
|
56.48
|
1,129,600
USD
|
|
|
2023-09-19 |
2023-09-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
25,333
-2.3%
61.23
1,551,140
USD
|
25,333
-2.3%
|
61.23
|
1,551,140
USD
|
|
|
2023-09-19 |
2023-09-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
8,425
-0.8%
61.64
519,317
USD
|
8,425
-0.8%
|
61.64
|
519,317
USD
|
|
|
2023-09-19 |
2023-09-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
16,242
-1.4%
62.81
1,020,160
USD
|
16,242
-1.4%
|
62.81
|
1,020,160
USD
|
|
|
2023-09-05 |
2023-09-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-6.0%
64.70
1,294,000
USD
|
20,000
-6.0%
|
64.70
|
1,294,000
USD
|
|
|
2023-08-30 |
2023-08-29 |
S
Sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
25,000
-2.2%
63.37
1,584,250
USD
|
25,000
-2.2%
|
63.37
|
1,584,250
USD
|
|
|
2023-08-30 |
2023-08-28 |
S
Sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
25,000
-2.1%
63.06
1,576,500
USD
|
25,000
-2.1%
|
63.06
|
1,576,500
USD
|
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Marken James G.
SVP OPS & PROD DEV
Officer
|
3,932
-2.9%
63.00
247,716
USD
|
3,932
-2.9%
|
63.00
|
247,716
USD
|
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
2,059
-3.3%
62.39
128,461
USD
|
2,059
-3.3%
|
62.39
|
128,461
USD
|
|
|
2023-08-25 |
2023-08-23 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
13,502
-17.7%
62.39
842,390
USD
|
13,502
-17.7%
|
62.39
|
842,390
USD
|
|
|
2023-08-16 |
2023-08-16 |
S
Sale
|
MERIDIAN VENTURE PARTNERS II LP
Large shareholder
|
200,000
-9.9%
58.50
11,700,000
USD
|
200,000
-9.9%
|
58.50
|
11,700,000
USD
|
|
|
2023-08-16 |
2023-08-15 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
22,110
-1.8%
61.60
1,361,976
USD
|
22,110
-1.8%
|
61.60
|
1,361,976
USD
|
|
|
2023-08-15 |
2023-08-15 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
11,616
-3.2%
61.13
710,086
USD
|
11,616
-3.2%
|
61.13
|
710,086
USD
|
|
|
2023-08-16 |
2023-08-14 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
17,639
-10.2%
61.37
1,082,505
USD
|
17,639
-10.2%
|
61.37
|
1,082,505
USD
|
|
|
2023-08-16 |
2023-08-14 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
27,890
-2.3%
61.15
1,705,474
USD
|
27,890
-2.3%
|
61.15
|
1,705,474
USD
|
|
|
2023-08-15 |
2023-08-14 |
S
Sale
|
Pera Antonio R
Non-Executive Director
|
3,000
-8.2%
60.37
181,110
USD
|
3,000
-8.2%
|
60.37
|
181,110
USD
|
|
|
2023-08-15 |
2023-08-11 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
56,666
-13.8%
57.75
3,272,462
USD
|
56,666
-13.8%
|
57.75
|
3,272,462
USD
|
|
|
2023-08-03 |
2023-08-01 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-5.7%
51.06
1,021,200
USD
|
20,000
-5.7%
|
51.06
|
1,021,200
USD
|
|
|
2023-07-21 |
2023-07-21 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
11,500
-0.9%
52.56
604,440
USD
|
11,500
-0.9%
|
52.56
|
604,440
USD
|
|
|
2023-07-21 |
2023-07-20 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
6,000
-0.5%
51.52
309,120
USD
|
6,000
-0.5%
|
51.52
|
309,120
USD
|
|
|
2023-07-21 |
2023-07-19 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
5,969
-0.5%
51.48
307,284
USD
|
5,969
-0.5%
|
51.48
|
307,284
USD
|
|
|
2023-07-18 |
2023-07-18 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
6,700
-0.5%
51.84
347,328
USD
|
6,700
-0.5%
|
51.84
|
347,328
USD
|
|
|
2023-07-18 |
2023-07-17 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
9,831
-0.8%
51.06
501,971
USD
|
9,831
-0.8%
|
51.06
|
501,971
USD
|
|
|
2023-07-18 |
2023-07-14 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
10,000
-0.8%
50.43
504,300
USD
|
10,000
-0.8%
|
50.43
|
504,300
USD
|
|
|
2023-07-06 |
2023-07-03 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-5.4%
53.43
1,068,600
USD
|
20,000
-5.4%
|
53.43
|
1,068,600
USD
|
|
|
2023-06-23 |
2023-06-22 |
PS
Planned sale
|
Gassert Chad
SVP - CORP. DEV. & STRATEGY
Officer
|
20,000
-5.1%
51.32
1,026,400
USD
|
20,000
-5.1%
|
51.32
|
1,026,400
USD
|
|
